On April 19th an FDA advisory committee voted unanimously to recommend approval of the first prescription cannabidiol medicine — to treat rare and severe forms of epilepsy. The drug is known as... read more
On April 19th an FDA advisory committee voted unanimously to recommend approval of the first prescription cannabidiol medicine — to treat rare and severe forms of epilepsy. The drug is known as... read more
A proposed $20 million settlement has been reached in a class action lawsuit involving the antibiotic drug Solodyn. The lawsuit claims that Medicis Pharmaceutical Corp., Impax Laboratories, Inc.,... read more
Genocea Biosciences, Inc. (NASDAQ:GNCA), a biopharmaceutical company developing neoantigen cancer vaccines, announced on 4/30/18 the filing of an Investigational New Drug (IND) Application with... read more
NanOlogy LLC, a clinical-stage pharmaceutical development company, has completed the dose escalation phase of an open-label clinical trial of NanoPac (submicron particle paclitaxel (Taxol) sterile... read more
LCS Group, LLC (“LCS”) announced today that it has filed a federal lawsuit in the Southern District of New York against Shire Plc, Shire Development LLC, and Shire LLC (“Shire”) alleging Shire... read more